INBS (INBS) Stock Price & Analysis
INBS (INBS) fell 3.04% to USD 2.23 as of September 8, 2026 at 08:21 UTC, according to Nexqual real-time market data.
INBS last closed at USD 2.23; the session ranged USD 2.15–2.39 on volume of 91,240 shares. Market capitalization is —, with a 52-week range of USD 1.52–24.9 (NCM). Source: Nexqual, September 8, 2026 at 08:21 UTC.
Key Statistics (as of September 8, 2026 at 08:21 UTC)
| Price | USD 2.23 |
|---|---|
| Change | ▼ 3.04% (down) |
| Previous Close | USD 2.23 |
| Open | USD 2.23 |
| Day Range | USD 2.15 – 2.39 |
| 52-Week Range | USD 1.52 – 24.9 |
| Volume | 91,240 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (INBS)
Nexqual's technical model rates INBS "NEUTRAL" based on 3 bullish and 3 bearish signals across 128 daily candles, as of September 8, 2026 at 08:21 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 47.16 (neutral) |
| vs SMA50 | Above (USD 2.21) |
| MACD | 0.03 (positive) |
From INBS's Latest SEC 10-K Filing (filed 2026-08-19)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CDIO | Cardio Diagnostics Holdings Inc | USD 1.86 | ▲ 1.09% |
| TNON | Tenon Medical, Inc. | USD 3.72 | ▼ 16.78% |
| BDRX | Biodexa Pharmaceuticals plc | USD 0.85 | ▲ 8.03% |
| SPRC | SciSparc Ltd. | USD 5.29 | ▼ 9.57% |
| HSCS | HeartSciences Inc. | USD 3.73 | ▲ 23.92% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 08:21 UTC. This page is informational and not investment advice.